Inhibitors | Comment | Organism | Structure |
---|---|---|---|
CDP | - |
Rattus norvegicus | |
CMP | - |
Rattus norvegicus | |
CTP | - |
Rattus norvegicus | |
Monoclonal antibody M12GC7 | - |
Rattus norvegicus |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.00011 | - |
lactosylceramide | - |
Rattus norvegicus | |
0.00026 | - |
CMP-N-acetylneuraminate | - |
Rattus norvegicus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
Golgi apparatus | - |
Rattus norvegicus | 5794 | - |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mn2+ | - |
Rattus norvegicus |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
60000 | - |
x * 60000, SDS-PAGE | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
glycoprotein | N- and O-linked carbohydrate side chains, containing sialic acids in alpha-2,3 and 2,6-linkage, galactose and galactosamine, branched N-glycans containing mannose | Rattus norvegicus |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
liver | - |
Rattus norvegicus | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
0.0055 | - |
- |
Rattus norvegicus |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
CMP-N-acetylneuraminate + beta-D-galactosyl-1,3-N-acetylgalactosamin-1,4-beta-D-galactosyl-1,4-beta-D-glucosylceramide | i.e. asialo-ganglioside GM1, sialylated at about 84% the rate of lactosylceramide | Rattus norvegicus | CMP + ? | - |
? | |
CMP-N-acetylneuraminate + beta-D-galactosyl-1,4-beta-D-glucosylceramide | preferred acceptors have the general structure beta1-O-ceramide, disaccharides are preferred to monosaccharide | Rattus norvegicus | CMP + N-acetylneuraminyl-2,3-beta-D-galactosyl-1,4-beta-D-glucosylceramide | i.e. ganglioside GM3 | ? | |
CMP-N-acetylneuraminate + beta-D-galactosyl-1,4-beta-D-glucosylceramide | no acceptors are fetuin, mucin, alpha1-acid glycoprotein, glycophorin or their respective asialo-derivatives, gangliosides GD1b, GM3, GM2, GM1 or GD1a | Rattus norvegicus | CMP + N-acetylneuraminyl-2,3-beta-D-galactosyl-1,4-beta-D-glucosylceramide | i.e. ganglioside GM3 | ? | |
CMP-N-acetylneuraminate + galactosylceramide | sialylated at about 40% the rate of lactosylceramide | Rattus norvegicus | CMP + ? | - |
? | |
CMP-N-acetylneuraminate + glucosylceramide | sialylated at about 65% the rate of lactosylceramide | Rattus norvegicus | CMP + ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
? | x * 60000, SDS-PAGE | Rattus norvegicus |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
additional information | - |
pI: 5.7-6.2 | Rattus norvegicus |
6.5 | - |
- |
Rattus norvegicus |
pH Minimum | pH Maximum | Comment | Organism |
---|---|---|---|
6.1 | 7.6 | detectable activity | Rattus norvegicus |